Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Eliem Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ELYM
Nasdaq
8731
https://eliemtx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Eliem Therapeutics Inc
Eliem Therapeutics Shifts From Neurology With New Found Focus On Autoimmune Diseases With Tenet Medicines Deal
- Apr 11th, 2024 6:42 pm
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
- Apr 11th, 2024 11:00 am
Here's Why We're Not Too Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Situation
- Mar 6th, 2024 5:51 pm
Eliem Therapeutics (NASDAQ:ELYM) Is In A Good Position To Deliver On Growth Plans
- Sep 28th, 2023 5:30 pm
Eliem (ELYM) to Explore Strategic Options, Stock Rises 6%
- Jul 21st, 2023 11:17 am
Eliem Therapeutics Announces Plans to Explore Strategic Alternatives
- Jul 20th, 2023 10:45 am
Eliem Therapeutics Reports First Quarter Financial Results and Business Highlights
- May 11th, 2023 8:10 pm
We're Hopeful That Eliem Therapeutics (NASDAQ:ELYM) Will Use Its Cash Wisely
- Apr 21st, 2023 4:00 pm
Top 10 Stocks Activist Investors Are Targeting
- Apr 21st, 2023 2:39 pm
Scroll